Landscape Capital Management, L.L.C. Macrogenics Inc Transaction History

Landscape Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$11.11 - $25.6 $312,335 - $719,692	-28,113 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.75 - $21.42 $146,781 - $267,578	12,492 Added 79.97%	28,113 $357,000
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $332,735 - $405,294	-17,276 Reduced 52.52%	15,621 $335,000
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $290,291 - $362,056	-14,676 Reduced 30.85%	32,897 $679,000
Q1 2018 May 11, 2018	BUY	$18.89 - $32.46 $898,653 - $1.54 Million	47,573 New	47,573 $1.2 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.